Private Wealth Partners’s GSK GSK Stock Holding History

Private Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,480	Closed	-$420K	–	125
2017 Q4	$420K	Hold	9,480	–	–	0.08%	98
2017 Q3	$481K	Hold	9,480	–	–	0.1%	90
2017 Q2	$511K	Sell	9,480 -120	-1%	-$6.4K	0.11%	82
2017 Q1	$506K	Buy	9,600 +2,466	+35%	+$125K	0.11%	80
2016 Q4	$343K	Sell	7,134 -786	-10%	-$38.8K	0.08%	89
2016 Q3	$427K	Hold	7,920	–	–	0.1%	87
2016 Q2	$429K	Sell	7,920 -160	-2%	-$8.43K	0.1%	92
2016 Q1	$410K	Sell	8,080 -40	-0.5%	-$1.99K	0.1%	94
2015 Q4	$410K	Buy	8,120 +3,120	+62%	+$159K	0.1%	101
2015 Q3	$240K	Hold	5,000	–	–	0.06%	118
2015 Q2	$260K	Buy	5,000 +840	+20%	+$47.3K	0.06%	127
2015 Q1	$240K	Buy	+4,160	New	+$238K	0.06%	131

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Private Wealth Partners's GSK Position: Q1 2018 in Review

Private Wealth Partners sold out of GSK (GSK) in Q1 2018, closing a stake of 9,480 shares — an estimated $420K sold.

Private Wealth Partners first reported a position in GSK in Q1 2015 and held it in 12 quarters. The position peaked at $511K in Q2 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Private Wealth Partners reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Private Wealth Partners sold 9,480 GSK shares in Q1 2018, an estimated $420K.
Private Wealth Partners first reported a position in GSK in Q1 2015 and held it in 12 quarters.
Private Wealth Partners's GSK position peaked at $511K in Q2 2017.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Private Wealth Partners's 13F filing for Q1 2018, filed 15 May 2018.